01 1Cipla
01 1PALONOSETRON HYDROCHLORIDE USP
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2014-01-27
Pay. Date : 2013-09-20
DMF Number : 27528
Submission : 2013-09-27
Status : Active
Type : II
20
Cipla Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is PALONOSETRON HYDROCHLORIDE USP, with a corresponding US DMF Number 27528.
Remarkably, this DMF maintains an Active status since its submission on September 27, 2013, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 27, 2014, and payment made on September 20, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II
